Gates Foundation grants $826K to Mass. biotech

04/4/2013 | American City Business Journals

The Bill & Melinda Gates Foundation, through its Grand Challenges Explorations initiative, awarded Tetragenetics a Phase II grant worth $826,000 to develop a more effective oral vaccine for malaria. The grant builds on a 2009 Phase I grant.

View Full Article in:

American City Business Journals

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ